[jfarlow]

Small biotech cofounder here - curious how you think about lab supplies and interactions with other of your customers. One thing that is curious is that you have a list of your life-science customers, but that's also a list of clients/suppliers for other of your clients. Is there any (potential) interaction in that regard between your clients? That seems to be one of the 'perks' in the generic tech industry - trading services between horizontal players. That might be a useful strategy here too. Even more than I want Uber rides, I want DNA, RNA, and other biotech services & products (that might be provided by these other clients).

Also curious about your interaction with CLSA - they're a pretty cool group that, as you mention, serves as a node or hub in the community. What does your interaction with them look like? To some extent they already provide some portal into the larger lab suppliers. It's not on the payment side, but more on the buying power itself.

Helping comply with government-approved accounting would also be a very nice feature for those of us that make use of SBIR-type grants. Though I suspect that that would mostly be true for much smaller biotech startups.

[hdubugras]

Thanks for the questions! To your first point, there's definitely some potential interaction between our customers. We're not quite sure what that will look like right now, but we do have our eyes on that in the future. We offer discounts on goods and services through our rewards portal so there's always the possibility of getting customers involved with that.

We're actually partnered with CLSA! You can read more about that here (https://finance.yahoo.com/news/brex-launches-first-corporate...) and if you're a CLSA member you'll start to see some communication about our partnership in the coming days/weeks.

Helping you comply with SBIR-type grants is definitely something we're researching. We actually already have some expense management tools (such as our receipt capture/handling) that make it easier to comply and will continue to work to make them better.